patients treated with levothyroxine for different causes of hypothyroidism
Comparison of triiodothyronine level in patients treated with levothyroxine for different causes of hypothyroidism
Objective: Several lines of evidence suggest that the symptoms of hypothyroidism, including psychological symptoms and metabolic effects, persist in a significant percentage of patients treated with levothyroxine (L-T4). A hypothesis to explain this phenomenon is that the triiodothyronine (L-T3) serum levels may not be completely normalized
Hyperandrogenism
Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome
One of the main features of polycystic ovary syndrome (PCOS) is increased adipose tissue, which can result in hormonal disturbances. In the present study, we aimed to investigate which indicator of obesity could better associate with hormonal disturbances in PCOS women.
The anti-obesity effects of postbiotics
The anti-obesity effects of postbiotics: A systematic review of pre-clinical and clinical studies
The growing prevalence of obesity has become a major concern worldwide, therefore a great number of studies are conducted every day in the field of obesity. Since postbiotics are a newly introduced term, there is not much systematic evidence about their function and impact on obesity. We designed this study to systematically review the effect of different types of postbiotics on obesity.
Pituitary tumor registry
Pituitary tumor registry: a multidisciplinary program protocol
This registry aims to collect information to create an appropriate platform for the development of a basis for clinical research and basic sciences to carefully study pituitary adenomas
Assessment of the initial results of pituitary
Assessment of the initial results of pituitary
Assessment of the initial results of pituitary tumor registry at a tertiary hospital of Iran: 2009–2022 The Pituitary Tumor Registry intends to provide a platform for clinical research and basic sciences, with an emphasis on disease outcomes.
Effect of resveratrol administration on ovarian morphology
Effect of resveratrol administration on ovarian morphology, determined by transvaginal ultrasound for the women with polycystic ovary syndrome (PCOS)
Intake of resveratrol has been associated with improved ovarian morphology under in vitro and in the animal models; however, this finding has not been confirmed in trials. The aim of our study was, therefore, to use a placebo-controlled approach with the detailed assessment of the ovarian morphology by applying transvaginal ultrasound to examine the effectiveness of this therapeutic approach in this group of women. The mean age of all participants was 28·61 (sd 4·99) years, with the mean BMI of 28·26 (sd 5·62) kg/m2